Technical Analysis for BHC - Bausch Health Companies Inc.

Grade Last Price % Change Price Change
grade A 33.67 -0.59% -0.200
BHC closed down 0.59 percent on Friday, February 15, 2019, on approximately normal volume.

Earnings due: Feb 28

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Up
See historical BHC trend table...

Date Alert Name Type % Chg
Feb 15 Bollinger Band Squeeze Range Contraction 0.00%
Feb 15 BB Squeeze Started Range Contraction 0.00%
Feb 12 NR7 Range Contraction 0.30%
Feb 11 Pocket Pivot Bullish Swing Setup 0.81%
Feb 8 Doji - Bullish? Reversal 3.66%
Feb 8 Down 3 Days in a Row Weakness 3.66%
Feb 7 Slingshot Bullish Bullish Swing Setup 2.87%
Feb 7 Upper Bollinger Band Walk Strength 2.87%
Feb 7 Overbought Stochastic Strength 2.87%
Feb 7 Gapped Down Weakness 2.87%

Older signals for BHC ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.
S&P/Tsx 60 Index Medicine Biotechnology Laser Psoriasis Acne Actinic Keratosis
Is BHC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 36.52
52 Week Low 23.6
Average Volume 1,027,124
200-Day Moving Average 0.0
50-Day Moving Average 30.3878
20-Day Moving Average 32.4675
10-Day Moving Average 33.383
Average True Range 1.0314
ADX 25.23
+DI 30.8554
-DI 17.5377
Chandelier Exit (Long, 3 ATRs ) 31.4258
Chandelier Exit (Short, 3 ATRs ) 32.5642
Upper Bollinger Band 34.5736
Lower Bollinger Band 30.3614
Percent B (%b) 0.79
BandWidth 12.973589
MACD Line 0.9525
MACD Signal Line 0.9093
MACD Histogram 0.0432
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 35.260
Resistance 3 (R3) 35.367 34.943 34.995
Resistance 2 (R2) 34.943 34.538 34.890 34.907
Resistance 1 (R1) 34.307 34.288 34.095 34.200 34.818
Pivot Point 33.883 33.883 33.778 33.830 33.883
Support 1 (S1) 33.247 33.478 33.035 33.140 32.522
Support 2 (S2) 32.823 33.228 32.770 32.433
Support 3 (S3) 32.187 32.823 32.345
Support 4 (S4) 32.080